Coronavirus Outbreak

Antibodies From Patients Infected With SARS-CoV In 2003 Cross-Neutralised SARS-CoV-2 In Vitro: Study

Scientists analysed 20 convalescent serum samples from patients infected with SARS-CoV, determining cross-reactivity for protein antigens derived from four regions of the SARS-CoV-2 spike protein

Published

on

Highlights
  • SARS-CoV antibodies can neutralise SARS-CoV-2 infection: Study
  • Findings may help develop vaccines against emerging and future coronavirus
  • The study was published in the journal Science Advances

Washington: Antibodies in serum samples collected from patients infected with SARS-CoV during the 2003 outbreak effectively neutralised SARS-CoV-2 infection in cultured cells, according to a new study. The study was published in the journal – Science Advances. The authors also report that, surprisingly, mice and rabbits immunised with a receptor-binding domain (RBD) from a strain of SARS-CoV that infects the Himalayan palm civet elicited stronger antibody responses against SARS-CoV-2 than animals immunised with an RBD from a human SARS-CoV strain.

The authors suggest that their findings may inform strategies to develop universal vaccines against emerging and future coronaviruses.

Also Read: No Shortage Of Oxygen Supply For Treatment Of COVID-19 Patients: Health Secretary

Yuanmei Zhu and colleagues analysed 20 convalescent serum samples from patients infected with SARS-CoV, determining cross-reactivity for protein antigens derived from four regions of the SARS-CoV-2 spike protein, including the S ectodomain (S), S1 subunit, RBD, and S2 subunit.

While all serum samples reacted strongly with the S and S2 proteins, they reacted more weakly with the S1 and RBD proteins. A separate test using a single-cycle infection assay determined that the convalescent SARS-CoV sera efficiently prevented both SARS-CoV and SARS-CoV-2 pseudoviruses (which cannot produce viral surface proteins on their own) from infecting cells, although they inhibited SARS-CoV-2 activity less efficiently.

The researchers verified their findings in animals and specifically characterized the RBD’s ability to mediate cross-reactivity in mice since the RBD is the least conserved of the spike protein sites between the two viruses. They found that anti-RBD serum from SARS-CoV cross-reacted well with SARS-CoV-2, suggesting a key antigen component is genetically conserved in the RBD sites of the two viruses.

Also Read: World Bank Praises Efforts To Arrest COVID-19 Spread In Mumbai’s Dharavi

Zhu notes that although antibody-dependent enhancement (when binding a virus to certain antibodies actually eases its entry into host cells) was not observed in this study, the effect should be addressed during vaccine development.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.) 

NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (WaterSanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollutionwaste managementplastic banmanual scavenging and sanitation workers and menstrual hygiene.  

[corona_data_new]

Leave a Reply

Your email address will not be published. Required fields are marked *

Exit mobile version